Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2022-06-15
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games inspired by the principles of the Early Start Denver Model (ESDM), one of the care programs validated in the management of young ASD.
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions\> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study).
The EQ5D questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gaming Open Library for Intervention in Autism at Home (GOLIAH /MICHELANGELO)
NCT02560415
Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder
NCT04607616
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
NCT06058104
Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)
NCT03020277
Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders
NCT02996708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The current study e-GOLIAH-ECO is a medico-economic study powered to recruit 150 children. It is a multisite randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions\> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D (quality of life) questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
The main objective is to evaluate the 12-month cost-effectiveness of the management of children diagnosed with ASDs using the e-GOLIAH game used at home, compared to usual management.
Secondary objective includes:
(i) To evaluate the cost-effectiveness ratio of the management of patients with ASDs using e-GOLIAH compared to usual management at 12 months of follow-up.
(ii) To explore the remaining ASD-related annual burden of the cost of disease for the two groups studied.
(iii) To evaluate the consequences of the generalization of the management of children diagnosed with ASD using e-GOLIAH, compared to a usual management, from the point of view of the Health Insurance over a period of 3 years.
(iv) To evaluate the impact of the management of children diagnosed with ASD using the e-GOLIAH game used at home, compared to usual management, on the patient's quality of life and that of their responsible parent and the correlation between the two, on adaptive symptoms, on autistic symptoms, on social interactions, on parental stress, at 6 months and at 12 months.
(v) To assess compliance with OS by children and their caregivers. The following scales will be monitored: the EQ5D-3L for quality of life, the Vineland-II scale, the Child Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), the Parenting Stress Index. In addition the medico-economic data will be monitored from regular interview and social insurance data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Children receiving the usual care plus intensive use of e-GOLIAH (experimental group)
"e-GOLIAH"
Usual care plus electronic tablet with games application "e-GOLIAH" (Gaming Open Library for Intervention in Autism at Home)
Control
Children receiving only the usual treatment (control group).
Usual care
Usual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"e-GOLIAH"
Usual care plus electronic tablet with games application "e-GOLIAH" (Gaming Open Library for Intervention in Autism at Home)
Usual care
Usual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 3 to 6 years;
* Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months.
* Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present
* Affiliation to a social security scheme (except AME)
* Children with behavioral problems;
* Unstabilized comorbid organic pathology;
* Moderate and severe cognitive deficit (Intellectual Quotient less than 55);
* Multi or polyhandicap.
* Medication that may cause visual or cognitive impairment (PSAs, neuroleptics, etc.) or that may interfere with the study assessments
* Degenerative diseases or any other disease that could interfere with the evaluations planned during this study (known epilepsy and/or history of seizures, etc.)
* Photosensitive persons in order to avoid situations that could induce epileptic seizures in them
3 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David COHEN, Professor
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval
Nice, Alpes Maritimes, France
Centre Hospitalier Universitaire de Strasbourg
Strasbourg, Bas-Rhin, France
Centre Hospitalier Universitaire de Toulouse
Toulouse, Haut-Garonne, France
Centre Hospitalier Universitaire de Montpellier
Montpellier, Hérault, France
Centre Hospitalier Universitaire de Tours
Tours, Indre-et-Loire, France
Centre Hospitalier Universitaire de Nancy
Nancy, Meurthe-et-Moselle, France
Centre Hospitalier d'Amiens
Amiens, Somme, France
Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit
Poitiers, Vienne, France
Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière
Paris, Île-de-France Region, France
Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences
Paris, Île-de-France Region, France
Assistance Publique - Hôpitaux de Paris, Site de Necker
Paris, Île-de-France Region, France
Centre Hospitalier de Versailles - André Mignot
Versailles, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Professor Jean-Philippe RAYNAUD, Child Psychiatrist
Role: primary
Professor Frédérique BONNET-BRILHAULT, Child Psychiatrist
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010 Jan;125(1):e17-23. doi: 10.1542/peds.2009-0958. Epub 2009 Nov 30.
Jouen AL, Narzisi A, Xavier J, Tilmont E, Bodeau N, Bono V, Ketem-Premel N, Anzalone S, Maharatna K, Chetouani M, Muratori F, Cohen D; MICHELANGELO Study Group. GOLIAH (Gaming Open Library for Intervention in Autism at Home): a 6-month single blind matched controlled exploratory study. Child Adolesc Psychiatry Ment Health. 2017 Mar 22;11:17. doi: 10.1186/s13034-017-0154-7. eCollection 2017.
Bieleninik L, Geretsegger M, Mossler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey O, Finnemann J, Carpente J, Park AL, Grossi E, Gold C; TIME-A Study Team. Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial. JAMA. 2017 Aug 8;318(6):525-535. doi: 10.1001/jama.2017.9478.
Billeci L, Narzisi A, Tonacci A, Sbriscia-Fioretti B, Serasini L, Fulceri F, Apicella F, Sicca F, Calderoni S, Muratori F. An integrated EEG and eye-tracking approach for the study of responding and initiating joint attention in Autism Spectrum Disorders. Sci Rep. 2017 Oct 19;7(1):13560. doi: 10.1038/s41598-017-13053-4.
Bono V, Narzisi A, Jouen AL, Tilmont E, Hommel S, Jamal W, Xavier J, Billeci L, Maharatna K, Wald M, Chetouani M, Cohen D, Muratori F; MICHELANGELO Study Group. GOLIAH: A Gaming Platform for Home-Based Intervention in Autism - Principles and Design. Front Psychiatry. 2016 Apr 28;7:70. doi: 10.3389/fpsyt.2016.00070. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03389-30
Identifier Type: OTHER
Identifier Source: secondary_id
APHP200052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.